would it be fair to say, page-46

Surges, you ask "Why have there in 7 years of partnering efforts never any financial deals been struck, never any money been paid to protect our technologies?"

This is a great question.

Here's another one. Why would a company like P&G pay for use of technology which is not patent protected?

I doubt even GSK and these "other companies" you reference (are we supposed to guess who these are?)who supposedly "often early pay money to their partners to have them locked into financial pipelines..." etc etc, would only make such early payments provided that the technology they are paying for is patent protected. If this is not standard business practice, I'm happy to be corrected.

You also mention that "We are long overdue for material news on all partnering fronts and that we up to date have not received milestone payments in any form is a telling story."

Long overdue according to whom, and based on what standard? Is there a universally accepted, set time within which such material news should arise? If so, please enlighten us.

Exactly what is this "story" telling you Surges? It's telling me that there is currently no material news to report. The CEO has intimated that if/when there is such news, he will report it. I fail to see how you are able to conclude any more or less than this.